The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for a new monovalent ...

Cold Chain Technologies (CCT) is intensifying its expansion in the Asia Pacific (APAC) region through targeted investments ...

For potential new treatment combining BioArctic’s BrainTransporter technology with an undisclosed target in neurodegeneration ...

MS Pharma has inaugurated a biologics manufacturing facility in Saudi Arabia.

Asymchem, a global contract development and manufacturing organization (CDMO), has expanded its flow chemistry capabilities ...

Asimov, a synthetic biology company, entered a cell line development partnership with Ottimo Pharma, a biopharmaceutical ...

Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review, and automate ...

Bio-Rad Laboratories has introduced a new range of StarBright Dyes, providing greater choice and flexibility for spectral ...

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals Inc.’s lead investigational candidate, currently in clinical ...

The European Commission has granted marketing authorization for Yeytuo (lenacapavir)—Gilead Sciences Inc.’s twice-yearly ...

With over two decades of experience, Katcheves previously served at Teva, Bristol Myers Squibb, and Lonza Group.

The European Commission (EC) has approved Bio-Thera Solutions Inc.’s BAT2206 (ustekinumab), a biosimilar referencing Stelara.